Home/Filings/4/0001707925-25-000053
4//SEC Filing

Pfann Oliver 4

Accession 0001707925-25-000053

CIK 0001707925other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 8:06 PM ET

Size

37.2 KB

Accession

0001707925-25-000053

Insider Transaction Report

Form 4
Period: 2025-03-07
Pfann Oliver
Senior Vice President, EMEA
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+6503,283.463 total
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+3953,346.442 total
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh201.767$94,5823,144.675 total
  • Award

    Performance Share Units (ROC)

    2025-03-10+650650 total
    Exercise: $0.00Ordinary Shares (650 underlying)
  • Award

    Performance Share Units (RTSR)

    2025-03-10+395395 total
    Exercise: $0.00Ordinary Shares (395 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-102150 total
    Ordinary Shares (215 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-10+2152,743.286 total
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh332.021$155,6412,951.442 total
  • Exercise/Conversion

    Performance Share Units (ROC)

    2025-03-106500 total
    Exercise: $0.00Ordinary Shares (650 underlying)
  • Exercise/Conversion

    Performance Share Units (RTSR)

    2025-03-103950 total
    Exercise: $0.00Ordinary Shares (395 underlying)
  • Award

    Restricted Stock Units

    2025-03-07+981981 total
    Exercise: $0.00Ordinary Shares (981 underlying)
  • Award

    Stock Options (right to buy)

    2025-03-07+6,8906,890 total
    Exercise: $468.77Exp: 2035-03-07Ordinary Shares (6,890 underlying)
  • Tax Payment

    Ordinary Shares

    2025-03-10$468.77/sh109.823$51,4822,633.463 total
Holdings
  • Stock Options (right to buy)

    Exercise: $253.68Exp: 2031-03-08Ordinary Shares (3,055 underlying)
    3,055
  • Stock Options (right to buy)

    Exercise: $465.29Exp: 2034-03-07Ordinary Shares (5,840 underlying)
    5,840
  • Restricted Stock Units

    Ordinary Shares (905 underlying)
    905
  • Restricted Stock Units

    Ordinary Shares (230 underlying)
    230
  • Stock Options (right to buy)

    Exercise: $173.13Exp: 2030-03-09Ordinary Shares (3,590 underlying)
    3,590
  • Stock Options (right to buy)

    Exercise: $270.99Exp: 2032-03-07Ordinary Shares (620 underlying)
    620
  • Stock Options (right to buy)

    Exercise: $354.14Exp: 2033-03-07Ordinary Shares (1,000 underlying)
    1,000
Footnotes (15)
  • [F1]Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022.
  • [F10]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
  • [F11]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
  • [F12]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
  • [F13]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
  • [F14]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
  • [F15]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
  • [F2]Ordinary shares withheld from the payout to cover tax withholdings.
  • [F3]Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022.
  • [F4]The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
  • [F5]The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
  • [F6]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis
  • [F7]Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F8]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F9]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

Issuer

LINDE PLC

CIK 0001707925

Entity typeother

Related Parties

1
  • filerCIK 0001989532

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:06 PM ET
Size
37.2 KB